Cisco Beats Earnings On Top And Bottom Lines Again
Article By:
Zacks Investment Research
Read
Wednesday, November 12, 2014 6:10 PM EDT
Cisco beats, guides lower than expected; CFO to leave.
In this article: CSCO
SeaWorld Flops Its Most Important Quarter Of The Year
Article By:
Leigh Drogen
Read
Wednesday, November 12, 2014 5:23 PM EDT
SeaWorld stock fell by more than 9% Wednesday after the company announced reduced park traffic, falling revenue, and dwindling profits in its critical summer quarter.
In this article: SEAS
Mystery Solved
Article By:
Tim Knight
Read
Wednesday, November 12, 2014 1:39 PM EDT
Yahoo’s 15% stake in Alibaba constitutes virtually the entire value of YHOO. Roughly speaking, this stake is worth nearly $44 billion…
Canadian Solar Beats On Q3 Earnings As Revenues Soar
Article By:
Zacks Investment Research
Read
Wednesday, November 12, 2014 1:18 PM EDT
Solar cell manufacturer Canadian Solar Inc. reported earnings of $1.75 per share.
In this article: CSIQ
Retail Earnings Mixed Thus Far, Wal-Mart, Nordstrom And Kohl’s Out Tomorrow
Article By:
Leigh Drogen
Read
Wednesday, November 12, 2014 12:41 PM EDT
Fossil reported third quarter results last night, blowing past both the Wall Street and Estimize consensus. Results from Macy’s this morning were mixed.
Macy's Q3 Earnings Beat Estimates, Sales Miss, Outlook Cut
Article By:
Zacks Investment Research
Read
Wednesday, November 12, 2014 12:34 PM EDT
Macy’s Inc. posted third-quarter fiscal 2014 results, wherein earnings of 61 cents a share.
In this article: M
Silver Wheaton Reports Third Quarter Results For 2014
Article By:
TalkMarkets DailyTalk
Read
Wednesday, November 12, 2014 8:34 AM EDT
Earnings drop; revenues are consistent but miss expectations.
In this article: SLW
D.R. Horton Misses Q4 Earnings On Higher Costs, Sales Beat
Article By:
Zacks Investment Research
Read
Tuesday, November 11, 2014 12:17 PM EDT
D.R. Horton Inc.’s adjusted earnings of 45 cents per share in the fourth quarter of fiscal 2014 missed the Zacks Consensus Estimate of 49 cents by 8.2%.
In this article: DHI
Achillion Pharmaceuticals Continues To Impress With Hepatitis C Results In A Combination Study
Article By:
Terry Chrisomalis
Read
Tuesday, November 11, 2014 10:55 AM EDT
ACH-3102 showed 100% Hepatitis C virus clearance in combination with Gilead's sofosbuvir.
Morning Call - 11/11/2014
Article By:
Jim Van Meerten
Read
Tuesday, November 11, 2014 9:35 AM EDT
December E-mini S&Ps (ESZ14 +0.17%) this morning are up +0.07% at a fresh record high on optimism the U.S. economy can weather a global slowdown and the end of the Fed's bond purchases.